| Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy (NCT03238976) | University of Chicago | 2017-09-11 |
| Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer (NCT03025035) | Yuan Yuan | 2017-09-10 |
| Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation (NCT03544762) | National Taiwan University Hospital | 2017-09-08 |
| Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study (NCT03432429) | Imperial College London | 2017-09-05 |
| Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease (NCT03095352) | Laura Huppert, MD, BA | 2017-09-02 |
| Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer (NCT04389424) | Instituto Jalisciense de Cancerologia | 2017-09-01 |
| EMDR Psychotherapy to Treat Anxious-depressive Symptoms in Breast Cancer Patient (NCT03271476) | Centre Hospitalier Régional Metz-Thionville | 2017-09-01 |
| The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting (NCT03232541) | Västernorrland County Council, Sweden | 2017-09-01 |
| Decision-aid on Breast Cancer Screening (NCT03097653) | Mario Negri Institute for Pharmacological Research | 2017-09-01 |
| A "Window Trial" on Boswellia for Breast Cancer Primary Tumors (NCT03149081) | Medical University of South Carolina | 2017-08-31 |
| Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments (NCT03056755) | Novartis Pharmaceuticals | 2017-08-29 |
| Efficacy of Preoperative Pectoral Nerve Block for Intraoperative Opioid Sparing Effect and Postoperative Analgesia (NCT03210220) | Gachon University Gil Medical Center | 2017-08-29 |
| A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab (NCT03264547) | Japan Breast Cancer Research Group | 2017-08-28 |
| A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1) (NCT03248492) | Daiichi Sankyo | 2017-08-25 |
| Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG (NCT03579979) | Chinese Academy of Sciences | 2017-08-24 |
| Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients (NCT03289364) | Providence Health & Services | 2017-08-24 |
| Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer (NCT03250676) | Eisai Inc. | 2017-08-23 |
| A Study of IMP4297 in Patients With Advanced Solid Tumors (NCT03508011) | Impact Therapeutics, Inc. | 2017-08-23 |
| Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection (NCT03265379) | University Health Network, Toronto | 2017-08-22 |
| Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors (NCT03392233) | RenJi Hospital | 2017-08-18 |
| Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer (NCT03255577) | Memorial Sloan Kettering Cancer Center | 2017-08-17 |
| The Impact of a Web-based Patient Decision Aid for Women Considering Breast Reconstruction (NCT03791138) | The Netherlands Cancer Institute | 2017-08-16 |
| Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling (NCT03225170) | National Human Genome Research Institute (NHGRI) | 2017-08-15 |
| Rehabilitation After Breast Cancer (NCT03254875) | Danish Cancer Society | 2017-08-15 |
| Treatment After Palbociclib-containing Regimens (NCT04517318) | Fudan University | 2017-08-15 |
| Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN) (NCT03365895) | University of Arizona | 2017-08-11 |
| Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer (NCT04072718) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2017-08-10 |
| A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer (NCT03186937) | University of Wisconsin, Madison | 2017-08-10 |
| Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention (NCT02295059) | City of Hope Medical Center | 2017-08-09 |
| Development of a Response Signature to Neoadjuvant Chemotherapy for Breast Cancer (NCT03314870) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2017-08-07 |
| Liquid Biopsy Evaluation and Repository Development at Princess Margaret (NCT03702309) | University Health Network, Toronto | 2017-08-03 |
| PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy (NCT02448576) | wang shusen | 2017-08-01 |
| Study of Stereotactic Radiotherapy for Breast Cancer (NCT03043794) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-08-01 |
| Purpose Project: Reclaiming Life Purpose After Breast Cancer (Feasibility Study) (NCT03233334) | Allina Health System | 2017-08-01 |
| The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers (NCT03211572) | Ottawa Hospital Research Institute | 2017-08-01 |
| Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients (NCT03581630) | Gangnam Severance Hospital | 2017-07-29 |
| IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA) (NCT04012229) | Centre Hospitalier Universitaire de Besancon | 2017-07-28 |
| Development of Clinical and Biological Database (NCT03449264) | Institut du Cancer de Montpellier - Val d'Aurelle | 2017-07-27 |
| Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast (NCT03154281) | Avera McKennan Hospital & University Health Center | 2017-07-26 |
| Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab (NCT03135171) | University of Michigan Rogel Cancer Center | 2017-07-26 |
| Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy (NCT03750240) | NYU Langone Health | 2017-07-25 |
| Understanding and Predicting Breast Cancer Events After Treatment (NCT02791581) | Wake Forest University Health Sciences | 2017-07-21 |
| Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases (NCT03239756) | Jiangsu T-Mab Biopharma Co.,Ltd | 2017-07-20 |
| Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China (NCT03792529) | Peking University Cancer Hospital & Institute | 2017-07-20 |
| A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer (NCT03306472) | Cambridge University Hospitals NHS Foundation Trust | 2017-07-20 |
| Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer (NCT02767661) | Sun Yat-sen University | 2017-07-19 |
| Reducing Distress and Depressive-symptoms in Rural Women (NCT03465813) | University of Nebraska | 2017-07-19 |
| Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer Patients (NCT03762642) | King Abdulaziz University | 2017-07-17 |
| Preoperative Breast Magnetic Resonance Imaging for Patients Undergoing Mammoplasty (NCT03173469) | Assiut University | 2017-07-15 |
| 500mg Fulvestrant in HR+ MBC (NCT03708432) | Fudan University | 2017-07-15 |
| Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer. (NCT03248427) | SOLTI Breast Cancer Research Group | 2017-07-13 |
| Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (NCT03155997) | Eli Lilly and Company | 2017-07-12 |
| Testing a Culturally Adapted Telephone Genetic Counseling Intervention (NCT03959267) | Georgetown University | 2017-07-07 |
| Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer (NCT02953860) | University of Colorado, Denver | 2017-07-06 |
| Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors (NCT03096041) | Centre Francois Baclesse | 2017-07-05 |
| Ex-vivo Performance Evaluation of the Histolog™ Scanner for Human Breast Carcinoma Detection on Fresh Breast Core Biopsies (NCT03530722) | Brust-Zentrum AG | 2017-07-04 |
| Preoperative Localization of Sentinel Lymph Node in Breast Cancer Patients By Novel Computed Tomography-Lymphography Guided Technique (NCT03442543) | Mansoura University | 2017-07-02 |
| 500mg Fulvestrant Versus Exemestane in MBC (NCT03575260) | Fudan University | 2017-07-01 |
| Feasibility in Identification of Breast Cancer Candidates for Elimination of Axillary Surgery (NCT05663021) | Fudan University | 2017-07-01 |
| Oncologic Therapy Support Via Means of a Dedicated Mobile App (NCT03168048) | Heidelberg University | 2017-07-01 |
| Breast Cancer Risk Assessment in Women Aged 40-49 (NCT03180086) | Beth Israel Deaconess Medical Center | 2017-07-01 |
| DTi Diffusion Findings in Breast MRI Screening and Diagnostic (NCT03158441) | Rabin Medical Center | 2017-07-01 |
| Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer (NCT03190083) | Case Comprehensive Cancer Center | 2017-07-01 |
| Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer (NCT02907918) | Washington University School of Medicine | 2017-06-30 |
| AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas (NCT03205176) | AstraZeneca | 2017-06-30 |
| The CAROLE (CArdiac Related Oncologic Late Effects) Study (NCT03235427) | Northwell Health | 2017-06-27 |
| Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. (NCT03161353) | MedSIR | 2017-06-26 |
| QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer (NCT03127098) | NantCell, Inc. | 2017-06-26 |
| Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer (NCT03112590) | H. Lee Moffitt Cancer Center and Research Institute | 2017-06-23 |
| Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer (NCT03430479) | Kyoto Breast Cancer Research Network | 2017-06-22 |
| Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy (NCT03199560) | Memorial Health University Medical Center | 2017-06-22 |
| Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer (NCT03430466) | Kyoto Breast Cancer Research Network | 2017-06-22 |
| Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer (NCT03078751) | Novartis Pharmaceuticals | 2017-06-20 |
| Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study (NCT03170648) | Dana-Farber Cancer Institute | 2017-06-19 |
| Patient-Assisted Compression - Impact on Image Quality and Workflow (NCT03196635) | GE Healthcare | 2017-06-19 |
| Effect of Preoperative Curcumin in Breast Cancer Patients (NCT03847623) | University of Malaya | 2017-06-18 |
| Performance of MammoAlert™, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or Older (NCT03243877) | POC Medical Systems, Inc. | 2017-06-17 |
| Safety and Efficiency of γδ T Cell Against Breast Cancer (NCT03183206) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer (NCT03007979) | Washington University School of Medicine | 2017-06-15 |
| Development of Distress Management Algorithms Using Mobile Device Based Health Logs in Breast Cancer Survivors (NCT03072966) | Asan Medical Center | 2017-06-13 |
| Pilot Study for 3-Dimensional Surface Imaging in Implant-based Breast Reconstruction (NCT03203252) | Royal Marsden NHS Foundation Trust | 2017-06-09 |
| Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer (NCT03186599) | Gachon University | 2017-06-08 |
| A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib (NCT03050398) | Novartis Pharmaceuticals | 2017-06-07 |
| PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery (NCT03084536) | Washington University School of Medicine | 2017-06-07 |
| AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy (NCT03092635) | Medical University of South Carolina | 2017-06-06 |
| Effects on the Personalized Rehabilitation Service in Patients With Cancer (NCT03200067) | Seoul National University Bundang Hospital | 2017-06-03 |
| Disposition of Dietary Polyphenols and Methylxanthines in Mammary Tissues From Breast Cancer Patients (NCT03482401) | National Research Council, Spain | 2017-06-01 |
| Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer (NCT03213925) | Instituto do Cancer do Estado de São Paulo | 2017-06-01 |
| Effect of a Topical Ketamine on Acute and Chronic Pain, Dose Finding (NCT03165149) | Assiut University | 2017-06-01 |
| Bridging the Gap: Incorporating Exercise Evidence Into Clinical Practice in Breast Cancer Care in Ontario (NCT03087461) | Hamilton Health Sciences Corporation | 2017-06-01 |
| PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors (NCT03149549) | CytomX Therapeutics | 2017-06-01 |
| Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors (NCT02538432) | University of Maryland, Baltimore | 2017-06-01 |
| Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening (NCT04877912) | University of Chicago | 2017-06-01 |
| Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer (NCT03580395) | Hebei Medical University Fourth Hospital | 2017-06-01 |
| Using Pranayama and Deep Breathing Exercises to Reduce Cancer-Related Fatigue and Insomnia During Radiotherapy (NCT04441827) | KTO Karatay University | 2017-06-01 |
| Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer (NCT03789851) | Shandong Cancer Hospital and Institute | 2017-06-01 |
| Comparative Analysis of Two Animal-derived ADMs in Irradiated Implant-based Reconstruction (NCT06139588) | European Institute of Oncology | 2017-06-01 |
| Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer (NCT03130439) | Dana-Farber Cancer Institute | 2017-05-26 |
| Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer (NCT03296683) | Real Imaging Ltd. | 2017-05-23 |
| Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients (NCT03872141) | Yale University | 2017-05-23 |